{
    "URL": "https://doi.org/10.1371/journal.pntd.0006108",
    "Published": "December 7, 2017",
    "Subject_Areas": [
        "Viral vaccines",
        "Vaccines",
        "Rabies virus",
        "Antibodies",
        "Vaccine development",
        "Antigens",
        "Body weight",
        "Virus glycoproteins"
    ],
    "Authors": {
        "Lothar Stitz": [
            "Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany"
        ],
        "Annette Vogel": [
            "Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany"
        ],
        "Margit Schnee": [
            "CureVac AG, T\u00fcbingen, Germany"
        ],
        "Daniel Voss": [
            "CureVac AG, T\u00fcbingen, Germany"
        ],
        "Susanne Rauch": [
            "CureVac AG, T\u00fcbingen, Germany"
        ],
        "Thorsten Mutzke": [
            "CureVac AG, T\u00fcbingen, Germany"
        ],
        "Thomas Ketterer": [
            "CureVac AG, T\u00fcbingen, Germany"
        ],
        "Thomas Kramps": [
            "CureVac AG, T\u00fcbingen, Germany"
        ],
        "Benjamin Petsch": [
            "CureVac AG, T\u00fcbingen, Germany"
        ]
    }
}